Revenue: The sum of all revenue fields included for a company's operating activities.
Royalty Pharma PLC (RPRX) had Revenue of $690.10M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$690.10M |
$144.68M |
|
-- |
|
$690.10M |
|
$279.27M |
|
$410.84M |
|
$-144.20M |
|
$266.64M |
|
$287.38M |
|
$266.64M |
|
$266.64M |
|
$266.64M |
|
$287.38M |
|
$410.84M |
|
$420.33M |
|
446.03M |
|
557.00M |
|
$0.32 |
|
$0.32 |
|
| Balance Sheet Financials | |
$1.53B |
|
$16.14B |
|
$17.94B |
|
$19.46B |
|
$1.18B |
|
$7.59B |
|
$8.49B |
|
$9.67B |
|
$9.80B |
|
$8.87B |
|
$9.80B |
|
1.01B |
|
| Cash Flow Statement Financials | |
$2.13B |
|
$-993.25M |
|
$-1.24B |
|
$618.70M |
|
$513.66M |
|
$-105.04M |
|
$333.94M |
|
$-679.22M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.29 |
|
-- |
|
-- |
|
0.44 |
|
0.88 |
|
100.00% |
|
59.53% |
|
59.53% |
|
-- |
|
38.64% |
|
20.96% |
|
$1.15B |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
19.21 |
|
4.69 |
|
2.72% |
|
3.01% |
|
1.37% |
|
1.53% |
|
$9.74 |
|
$2.07 |
|
$3.83 |
|